ALAMEDA, Calif., Dec. 20, 2018 /PRNewswire/ -- Penumbra, Inc.
(NYSE: PEN) today announced that its management team is scheduled
to present at the 37th Annual J.P. Morgan Healthcare
Conference in San Francisco, CA on
Tuesday, January 8, 2019.
Event:
|
37th
Annual J.P. Morgan Healthcare Conference
|
Date:
|
Tuesday, January 8,
2019
|
Time:
|
5:30pm ET / 2:30pm
PT
|
A webcast of the presentation will be available by visiting the
investors section of the company's website at www.penumbrainc.com.
The webcast will be available on the company's website for at
least two weeks following the event.
About Penumbra
Penumbra, Inc., headquartered in
Alameda, California, is a global
healthcare company focused on innovative therapies. Penumbra
designs, develops, manufactures and markets medical devices and has
a broad portfolio of products that addresses challenging medical
conditions and significant clinical needs. Penumbra sells its
products to hospitals primarily through its direct sales
organization in the United States,
most of Europe, Canada and Australia, and through distributors in select
international markets. The Penumbra P logo is a trademark of
Penumbra, Inc. For more information,
visit www.penumbrainc.com.
Investor Relations
Penumbra, Inc.
510-995-2461
investors@penumbrainc.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/penumbra-inc-to-present-at-the-37th-annual-jp-morgan-healthcare-conference-300769759.html
SOURCE Penumbra, Inc.